Media Center Found (27)
Array ( [cache_time] => 0 [counts_time] => 0 [query_time] => [total_time] => 0 )
May 1, 2019

Industry will meet innovation at a unique collaborative event between the Medical Cannabis Industry and leading experts at Hebrew U. HUJI currently holds the most academic patents worldwide in this field and is a leading pioneer in cannaboid...

More
May 1, 2019

In 2018, the Jerusalem institution’s tech transfer arm struck 25 licensing agreements in the field of cannabis, accounting for 10% of total licensing volume that year

More
May 1, 2019

May 1, 2019 – Jerusalem – Yissum, the technology transfer company of The Hebrew University of Jerusalem, is hosting a first-of-its kind conference to drive academic-industry collaboration across multiple cannabis-related research and development...

More
March 31, 2019

Tech-transfer is the birth place for new cannabis technologies and Dr. Yaron Daniely, CEO and President of Yissumhashtagand Dudu Bassa from Sterohashtagshared their knowledge and experience from both sides of the equation at CannaTechTel Aviv.

More
April 5, 2017

Therapix Biosciences Ltd. (NASDAQ, TASE: TRPX), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced that it has signed a sublicense agreement for Yissum Research...

More
April 5, 2017

Therapix Biosciences Ltd. (NASDAQ, TASE: TRPX), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced that it has signed a sublicense agreement for Yissum Research...

More
February 19, 2017

From research to agricultural and technical innovation and liberal government policies, Israel is a central hub for advancing medical cannabis.

More
December 24, 2016

No less than 50 Israeli start ups currently develop Cannabis-related technologies, and the Hebrew University's new startup CannabiTech is here to make a change. 

More
December 6, 2016

Nutraceutical pain reliever makes use of marijuana’s CBD compound, doesn’t make you high.
Sales based on Israeli startup Lyotropic Delivery Systems (LDS) Biotech‘s nanotechnology have started in the US. The commercial launch of its...

More
December 1, 2016

Revolutionary new technology gives cannabinoids unparalleled access to bloodstream.
Commercial launch by Ananada Scientific of HYGIA Nutrients Brand took place at the Marijuana Business Conference in Las Vegas.

More
November 16, 2016

Still controversial in the US, Israel is leading the way to develop the next generation of Medical Cannabis.
Just last month, Yissum (the technology transfer company of the Hebrew University) announced that Agrinnovation, its investment fund...

More
September 28, 2016

Agrinnovation puts money into Cannabi-Tech, developer of an analysis device for medical marijuana flowers

More
September 22, 2016

Yissum Research Development Company of the Hebrew University of Jerusalem, the technology-transfer company of the Hebrew University, announced today that Agrinnovation, an investment fund focused on agricultural inventions, has entered into an...

More
September 22, 2016

Agrinnovation, the agri-tech investment fund of Hebrew University of Jerusalem technology commercialization company Yissum, has announced an investment in a medical cannabis venture. Cannabi-Tech is based on research by cofounder and chief...

More
July 5, 2016

Therapix Biosciences, (OTCQB: THXBY) (TASE: THXBY.TA), a pharma company specializing in the development and commercialization of cannabinoid-based drugs, announced today that it entered into a binding memorandum of understandings with Yissum, the...

More
April 21, 2015

While medical cannabis is often used to ease pain or nausea, an Israeli-American biopharmaceutical company is developing medicines containing cannabinoids — chemical compounds from cannabis plants — to treat conditions including diabetes,...

More
March 23, 2015

The licensed intellectual property is the result of many years of research and collaboration between renowned cannabinoid scientists, Raphael Mechoulam, Professor of medicinal chemistry, and Ruth Gallily, Professor of immunology, both from the...

More
March 23, 2015

The licensed intellectual property is the result of many years of research and collaboration between renowned cannabinoid scientists, Raphael Mechoulam, Professor of medicinal chemistry, and Ruth Gallily, Professor of immunology, both from the...

More
January 27, 2015

The Hebrew University tech transfer company will collaborate on a novel delivery system.

More
January 26, 2015

Phytotech Medical went public on the Australian Securities Exchange raising AUS$5.9 million dollars 

More